Skip to main content
. 2009 Oct 7;2009(4):CD001246. doi: 10.1002/14651858.CD001246.pub2

ASCET.

Trial name or title ASpirin non‐responsiveness and Clopidogrel Endpoint Trial (ASCET)
Methods Randomised, open label
Participants 1000 patients with documented coronary heart disease
Interventions Continued treatment with aspirin 160 mg daily versus or change to clopidogrel 75 mg daily
Outcomes Composite of unstable angina, myocardial infarction, stroke or death
Starting date April 2003
Contact information http://clinicaltrials.gov/ct2/show/NCT00222261
Notes